|
|
|
|||||||||||
|
|||||||||||||||||||||||||||||||||||||||||||||
TB-Related ArticlesReturn to TB-Related Articles Table of Contents Journal Articles Published by Division of TB Elimination (DTBE) Authors January - December 2005 Butler WR, Floyd MM, Brown JM, Toney SR, Daneshvar MI, Cooksey RC, Carr J, Steigerwalt AG, Charles N. Novel mycolic acid-containing bacteria in the family Segniliparaceae fam. nov., including the genus Segniliparus gen. nov., with descriptions of Segniliparus rotundus sp. nov. and Segniliparus rugosus sp. nov. International Journal of Systematic and Evolutionary Microbiology 2005; 55: 1615-1624. Bozeman L, Burman W, Metchock B, Welch L, and Weiner
M. Fluoroquinolone susceptibility among Mycobacterium tuberculosis
isolates from the Burgos M, Gonzalez LC, Paz EA, Gournis E, Kawamura LM, Schecter G, Hopewell PC, and Daley CL. Treatment of multidrug-resistant tuberculosis in San Francisco: an outpatient-based approach. Clinical Infectious Diseases 2005 Apr 1; 40(7): 968-75. Cowan LS, Diem L, Monson T, Wand P, Temporado D, Oemig TV, and
Crawford JT. Evaluation of a two-step approach for large-scale,
prospective genotyping of Mycobacterium tuberculosis isolates in
the Dewan P, Sosnovskaja A, Thomsen V, Cicenaite J, Laserson K, Johansen I, Davidaviciene E, and Wells C. High prevalence of drug-resistant tuberculosis, Republic of Lithuania, 2002. International Journal of Tuberculosis and Lung Disease 2005 Feb; 9 (2): 170-4. Driver CR, Matus SP, Bayuga S, Winters AI, and Munsiff SS. Factors associated with tuberculosis treatment interruption in New York City. Journal of Public Health Management and Practice 2005 July/August; 11(4): 361-8. Frieden TR and Munsiff SS. The DOTS strategy for controlling the global tuberculosis epidemic. Clinics in Chest Medicine 2005 Jun; 26(2): 197-205. Granich RM, Oh P, Lewis B, Porco TC, Flood J. Multidrug resistance among persons with tuberculosis in California, 1994-2003. JAMA 2005 Jun 8; 293(22): 2732-9. Haddad MB, Wilson TW, Ijaz K, Marks SM, Moore M. Tuberculosis and homelessness in the United States, 1994–2003. JAMA 2005; 293(22): 2762-2766. Jasmer RM, Bozeman L, Schwartzman K, Cave MD, Saukkonen JJ, Metchock
B, Khan A, and Burman WJ. Recurrent tuberculosis in the Jasmer RM, Seaman CB, Gonzalez LC, Kawamura LM, Osmond DH, Daley CL. Tuberculosis treatment outcomes: directly observed therapy compared with self-administered therapy. American Journal of Respiratory and Critical Care Medicine 2004 Sep 1; 170 (5): 561-6. Kammerer JS, McNabb SJ, Becerra JE, Rosenblum L, Shang N, Iademarco MF, and Navin TR. Tuberculosis transmission in nontraditional settings: a decision-tree approach. American Journal of Preventive Medicine 2005 Feb; 28 (2): 201-7. Laserson KF, Binkin NJ, Thorpe LE, Laing R, Iademarco MF, Bloom A, Agerton TB, Nelson L, Cegielski JP, Ferroussier O, Holtz T, Vitek E, Gammino V, Tan K, Finlay A, Dewan P, Miranda A, Aquino G, Weyer K, Sy DN, Vernon A, Becerra J, Ershova J, Wells CD. Capacity building for international tuberculosis control through operations research training. International Journal of Tuberculosis and Lung Disease 2005; 9(2): 145-150. Laserson KF, Thorpe LE, Leimane V, Weyer K, Mitnick CD, Riekstina V, Zarovska E, Rich ML, Fraser HSF, Alarcón, Cegielski JP, Grzemska M, Gupta R, Espinal M. Speaking the same language: treatment outcome definitions for multidrug-resistant tuberculosis. International Journal of Tuberculosis and Lung Disease 2005; 9(6): 640-645. Laserson KF, Yen NTN, Thornton CG, Mai VTC, Jones W, An DQ, Phuoc
NH, Trinh NA, Nhung DTC, Lien TX, Lan NTN, Wells C, Binkin N, Cetron
M, Maloney SA. Improved sensitivity of sputum smear microscopy after
processing specimens with C18-carboxypropylbetaine to
detect acid-fast bacilli: a study of United States–bound immigrants
from Leimane V, Riekstina V, Holtz TH, Zarovska E, Skripconoka V, Thorpe
LE, Laserson KF, Wells CD. Clinical outcome of individualised treatment
of multidrug-resistant tuberculosis in Levy MZ, Medeiros EA, Shang N, Soares MC, Homenko AS, Almeida RM, Garrett DO, Roth VR, Jarvis WR, Wells CD, Binkin N, and Laserson KF. TST reversion in a BCG-revaccinated population of nursing and medical students, Sao Paulo, Brazil, 1997-2000. International Journal of Tuberculosis and Lung Disease 2005 Jul; 9 (7): 771-6. Li J, Munsiff SS, Driver CR, and Sackoff J. Relapse and acquired rifampin resistance in HIV-infected patients with tuberculosis treated with rifampin- or rifabutin-based regimens in New York City, 1997-2000. Clinical Infectious Diseases 2005 Jul 1; 41(1): 83-91. Lobato MN, Reves RR, Jasmer RM, Grabau JC, Bock NN, Shang N (2RZ Study Group). Adverse events and treatment completion for latent tuberculosis in jail inmates and homeless persons. Chest 2005; 127(4): 1296-1303. LoBue PA and Moser KS. Isoniazid- and rifampin-resistant tuberculosis in San Diego County, California, United States, 1993-2002. International Journal of Tuberculosis and Lung Disease 2005 May; 9(5): 501-6. LoBue PA and Moser KS. Treatment of Mycobacterium bovis–infected tuberculosis patients: San Diego County, California, United States, 1994-2003. International Journal of Tuberculosis and Lung Disease 2005 Mar; 9 (3): 333-8. Malakmadze N, Gonzalez IM, Oemig T, Isiadinso I, Rembert D, McCauley MM, Wand P, Diem L, Cowan L, Palumbo GJ, Fraser M, Ijaz K. Unsuspected recent transmission of tuberculosis among high-risk groups: implications of universal tuberculosis enotyping in its detection. Clinical Infectious Diseases 2005; 40: 366-373. Maus CE, Plikaytis BB, and Shinnick TM. Molecular analysis of cross-resistance to capreomycin, kanamycin, amikacin, and viomycin in Mycobacterium tuberculosis. Antimicrobial Agents and Chemotherapy 2005 Aug; 49(8): 3192-3197. Maus CE, Plikaytis BB, and Shinnick TM. Mutation of tlyA confers capreomycin resistance in Mycobacterium tuberculosis. Antimicrob Agents Chemother 2005; 49(2): 571-577. McElroy PD, Ijaz K, Lambert LA, Jereb JA, Iademarco MF, Castro KG, Navin TR. National survey to measure rates of liver injury, hospitalization, and death associated with rifampin and pyrazinamide for latent tuberculosis infection. Clinical Infectious Diseases 2005; 41: 1125-1133. Nelson LJ, Talbot EA, Mwasekaga MJ, Ngirubiu PK, Mwansa RA, Notha
M, Wells CD. Antituberculosis drug resistance and anonymous HIV
surveillance in tuberculosis patients in Pai M, Gokhale K, Joshi R, Dogra S, Kalantri S, Mendiratta DK,
Narang P, Daley CL, Granich RM, Mazurek GH, Reingold AL, Riley LW,
Colford JM. Mycobacterium tuberculosis infection in health care
workers in rural Santha T, Garg R, Subramani R, Chandrasekaran V, Selvakumar N, Sisodia RS, Perumal M, Sinha SK, Singh RJ, Chavan R, Ali F, Sarma SK, Sharma KM, Jagtap RD, Frieden TR, Fabio L, and Narayanan PR. Comparison of cough of 2 and 3 weeks to improve detection of smear-positive tuberculosis cases among out-patients in India. International Journal of Tuberculosis and Lung Disease 2005 Jan; 9 (1): 61-8. Schneider E. Tuberculosis Among American Indians and Alaska Natives in the United States, 1993-2002. American Journal of Public Health 2005; 95(5): 873-880. Schneider E, Moore M, and Castro KG. Epidemiology of tuberculosis
in the Selvakumar N, Sivagamasundari S, Prabhakaran E, Govindaraju R, Perumal M, Granich R, Wares F, Chauhan LS, and Narayanan PR. Storage of heat-fixed unstained sputum AFB smears for panel testing in a tuberculosis unit in South India. International Journal of Tuberculosis and Lung Disease 2005 Feb; 9 (2): 223-5. Skenders G, Fry AM, Prokopovica I, Greckoseja S, Broka L, Metchock B, Holtz TH, Wells CD, Leimane V. Multidrug-resistant tuberculosis detection, Latvia. Emerging Infectious Diseases 2005 Sept; 11(9): 1461-1463. Tappero JW, Bradford WZ, Agerton TB, Hopewell P, Reingold AL, Lockman
S, Oyewo A, Talbot EA, Kenyon TA, Moeti TL, Moffat HJ, and Peloquin
CA. Serum concentrations of antimycobacterial drugs in patients
with pulmonary tuberculosis in Weiner M, Benator D, Burman W, Peloquin CA, Khan A, Vernon A, Jones B, Silva-Trigo C, Zhao Z, and Hodge T. Association between acquired rifamycin resistance and the pharmacokinetics of rifabutin and isoniazid among patients with HIV and tuberculosis. Clinical Infectious Diseases 2005 May 15;40(10): 1481-91. Williams BG, Granich R, Chauhan LS, Dharmshaktu NS, Dye C. The
impact of HIV/AIDS on the control of tuberculosis in
Last Reviewed: 05/18/2008 |
|
|
If you would like to order any of the DTBE publications please visit the online order form. You will need Adobe Acrobat™ Reader v5.0 or higher to read pages that are in PDF format. Download the Adobe Acrobat™ Reader. If you have difficulty accessing any material on the DTBE Web site because of a disability, please contact us in writing or via telephone and we will work with you to make the information available. Division of Tuberculosis Elimination
Centers for Disease Control & Prevention |